Stockreport

Visionary Holdings (Nasdaq: GV) Secures Global License for Breakthrough Stem Cell Technology Aimed at Diabetes Remission and Potential Complete Cure in a USD 150 Billion Global Market [Yah...

Visionary Holdings Inc. - Common Shares  (GV) 
NASDAQ:AMEX Investor Relations: ir.goldfieldcorp.com
PDF listed on Nasdaq (Nasdaq: GV), today announced that its wholly owned subsidiary, Visionary Holdings (Asia) Limited , has entered into a Global Product and Technology Lic [Read more]